Latest gabapentin Stories
BURLINGTON, Mass., Oct. 6 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, although NeurogesX/Astellas's Qutenza is only approved for postherpetic neuralgia, surveyed U.S.
While the Food and Drug Administration (FDA) requires a warning of an increased risk of suicide for all epilepsy drugs, a new study shows that only certain drugs may increase the risk.
For patients with quadriplegia, mutism and lower cranial nerve paralysis (locked-in syndrome), their only means of interacting with others is through vertical gaze and upper eyelid movements, using eye-coded communication strategies.
PITTSBURGH, June 4 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S.
MELBOURNE, Australia and SAN FRANCISCO, May 28 /PRNewswire/ -- Relevare Pharmaceuticals Ltd.
NEW YORK, May 17 /PRNewswire-FirstCall/ -- In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. (NYSE: PFE) will give scientists at Washington University School of Medicine in St.
NEW YORK, March 25 /PRNewswire/ -- Following a month-long trial in United States District Court in Boston, a federal jury awarded Plaintiffs Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals over $47 million in damages, before mandatory trebling and interest.
WALTHAM, Mass., March 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that a novel formulation of Pfizer's Neurontin that is dosed once a day would earn a 50 percent patient share in the treatment of postherpetic neuralgia, according to surveyed U.S.
JERUSALEM, Feb. 2 /PRNewswire-FirstCall/ -- Teva Pharmaceutical Industries Ltd.
Despite government warnings about an increased risk of suicidal thoughts and actions while taking antiepileptic drugs, these medications do not appear to be associated with increased risk of suicide attempts in individuals with bipolar disorder, and may have a possible protective effect
- A poem in which the author retracts something said in an earlier poem.